Immuron Limited Gains 161.49%

Immuron Limited (IMRN:NASDAQ) soared at $4.55, representing a gain of 161.5%. On Thu, Mar 07, 2024, IMRN:NASDAQ touched a New 2-Week High of $4.55. The stock got featured on our News Catalysts scanner on Thu, Mar 07, 2024 at 07:57 AM in the 'BIOTECH' category. From Thu, Feb 22, 2024, the stock recorded 20.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Mar 07, 2024 at $5.96 with a volume of 52M+.

About Immuron Limited (IMRN:NASDAQ)

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.